Skip to main content
. 2017 Oct 13;8:167–174. doi: 10.1016/j.conctc.2017.10.003

Fig. 2.

Fig. 2

Flow chart/study overview. Flow chart of the study “Biomarkers and/or prognostic markers”. All patient material used is collected from the Pelvic mass cohort. The study contains 3 branches; a miRNA sub-study, an epigenetic sub-study and a NGS sub-study. Each sub-study aims at discovering and validating new biomarkers. OC: ovarian cancer, NGS: Next Generation Sequencing, Exome-seq: Exome sequencing.